[1] |
Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?[J]. Am J Transplant, 2004, 4(8):1289-1295. doi: 10.1111/ajt.2004.4.issue-8
|
[2] |
Henon PR, Butturini A, Gale RP. Blood-derived haematopoietic cell transplants: blood to blood?[J]. Lancet, 1991, 337(8747):961-963. doi: 10.1016/0140-6736(91)91583-G
|
[3] |
Alpdogan O, van den Brink MR. Immune tolerance and transplantation[J]. Semin Oncol, 2012, 39(6):629-642. doi: 10.1053/j.seminoncol.2012.10.001
|
[4] |
Kawai T, Sachs DH. Tolerance induction: hematopoietic chimerism[J]. Curr Opin Organ Transplant, 2013, 18(4):402-407. http://cn.bing.com/academic/profile?id=2045309203&encoded=0&v=paper_preview&mkt=zh-cn
|
[5] |
Pilat N, Wekerle T. Transplantation tolerance through mixed chimerism[J]. Nat Rev Nephrol, 2010, 6(10):594-605. doi: 10.1038/nrneph.2010.110
|
[6] |
Pilat N, Hock K, Wekerle T. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation[J]. Curr Opin Organ Transplant, 2012, 17(1):63-70. doi: 10.1097/MOT.0b013e32834ee68b
|
[7] |
LoCascio SA, Morokata T, Chittenden M, et al. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance[J]. Transplantation, 2010, 90(12):1607-1615. doi: 10.1097/TP.0b013e3181ffbaff
|
[8] |
Siemionow M, Klimczak A. Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience[J]. Clin Dev Immunol, 2013:831410. http://cn.bing.com/academic/profile?id=2169734765&encoded=0&v=paper_preview&mkt=zh-cn
|
[9] |
Li HW, Sykes M. Emerging concepts in haematopoietic cell transplantation[J]. Nat Rev Immunol, 2012, 12(6):403-416. doi: 10.1038/nri3226
|
[10] |
郭可泉, 孟旭, 韩杰, 等. 心脏移植后骨髓腔内供者骨髓移植诱导供者特异性免疫低反应性再探讨[J].中华器官移植杂志, 2013, 34(5):277-279.
Guo KQ, Meng X, Han J, et al. An improved strategy of intra-bone marrow-bone marrow transplantation in tolerance induction in clinical heart transplantation trials[J]. Chin J Organ Transplant, 2013, 34(5):277-279.
|
[11] |
Al-Adra DP, Anderson CC. Mixed chimerism and split tolerance: mechanisms and clinical correlations[J]. Chimerism, 2011, 2(4):89-101. doi: 10.4161/chim.2.4.19017
|
[12] |
Tsang JY, Tanriver Y, Jiang S, et al. Conferring indirect allospecificity on CD4+ CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice[J]. J Clin Invest, 2008, 118(11):3619-3628. doi: 10.1172/JCI33185
|
[13] |
Yamada Y, Boskovic S, Aoyama A, et al. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates[J]. Am J Transplant, 2012, 12(2):330-340. doi: 10.1111/j.1600-6143.2011.03795.x
|
[14] |
Geissler EK, Hutchinson JA. Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients[J]. Curr Opin Organ Transplant, 2013, 18(4):408-415. http://cn.bing.com/academic/profile?id=2077136844&encoded=0&v=paper_preview&mkt=zh-cn
|
[15] |
Pilat N, Wekerle T. Combining Treg therapy with mixed chimerism: getting the best of both worlds[J]. Chimerism, 2010, 1(1):26-29. doi: 10.4161/chim.1.1.12964
|
[16] |
Ruiz P, Maldonado P, Hidalgo Y, et al. Transplant tolerance: new insights and strategies for long-term allograft acceptance[J]. Clin Dev Immunol, 2013:210506. http://cn.bing.com/academic/profile?id=2158476280&encoded=0&v=paper_preview&mkt=zh-cn
|
[17] |
Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance[J]. Transpl Int, 2008, 21(12):1118-1135. doi: 10.1111/tri.2008.21.issue-12
|
[18] |
Spitzer TR, Sykes M, Tolkoff-Rubin N, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease[J]. Transplantation, 2011, 91(6):672-676. doi: 10.1097/TP.0b013e31820a3068
|
[19] |
Strober S, Spitzer TR, Lowsky R, et al. Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction[J]. Semin Immunol, 2011, 23(4):273-281. doi: 10.1016/j.smim.2011.05.001
|
[20] |
Kawai T, Sachs DH, Sykes M, et al. HLA-mismatched renal transplantation without maintenance immunosuppression[J]. N Engl J Med, 2013, 368(19):1850-1852. doi: 10.1056/NEJMc1213779
|
[21] |
Sachs DH, Sykes M, Kawai T, et al. Immuno-intervention for the induction of transplantation tolerance through mixed chimerism[J]. Semin Immunol, 2011, 23(3): 165-173. doi: 10.1016/j.smim.2011.07.001
|
[22] |
Andreola G, Chittenden M, Shaffer J, et al. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation[J]. Am J Transplant, 2011, 11(6):1236-1247. doi: 10.1111/j.1600-6143.2011.03566.x
|
[23] |
Farris AB, Taheri D, Kawai T, et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts[J]. Am J Transplant, 2011, 11(7):1464-1477. doi: 10.1111/ajt.2011.11.issue-7
|